The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Documenti analoghi

• Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
  di: Gordon, Calvin J., et al.
  Pubblicazione: (2020)
• Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
  di: Tchesnokov, Egor P., et al.
  Pubblicazione: (2019)
• Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
  di: Tchesnokov, Egor P., et al.
  Pubblicazione: (2020)
• Role of Helix P of the Human Cytomegalovirus DNA Polymerase in Resistance and Hypersusceptibility to the Antiviral Drug Foscarnet
  di: Tchesnokov, Egor P., et al.
  Pubblicazione: (2006)
• Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus
  di: Tchesnokov, Egor P., et al.
  Pubblicazione: (2018)